Hyperion DeFI Inc (EYEN) Live Share Price, Invest From India

Hyperion DeFI Inc Stock Performance

as on July 3, 2025 at 6:59 am IST

Day's Low
Day's High
$15.81
Day's Price Range
$15.81
$15.80
-0.06%
Downside
0.06%
Upside
52 Week's Low
52 Week's High
$1.03
52-Week Price Range
$14.33
$15.80
93.48%
Downside
-9.30%
Upside

Hyperion DeFI Inc share price movements today

Previous Close: $10.56
Open: $15.81
Volume: 165.0
Day's Low - High: $15.81 - $15.81
52 Week Low - High: $1.03 - $14.33

Hyperion DeFI Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Hyperion DeFI Inc Stock Fundamentals & Key Indicators

Check Hyperion DeFI Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

0.00%

Hyperion DeFI Inc stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Hyperion DeFI Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Hyperion DeFI Inc	BUY	$-	NA	NA	0.00%

Analyst Recommendation on Hyperion DeFI Inc Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Hyperion DeFI Inc. Average target price of $2

Hyperion DeFI Inc Share Price Target

Get share price movements and forecasts by analysts on Hyperion DeFI Inc.

What analysts predicted

-690%DOWNSIDE

Target Price

Current Price

$15.8

Analyzed by

10 Analysts

Target

$2.00

Hyperion DeFI Inc target price $2, a slight downside of -690% compared to current price of $15.8. According to 10 analysts rating.

Hyperion DeFI Inc Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Total Revenue	-	-	-	0	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	0	0	0	-3	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-5	-5	-6	-7	-7	-10	-11	-7	-19	-3
Net Profit Margin	0.00%	0.00%	0.00%	-612582.05%	-307730.28%	-218748.27%	-48856.13%	-485406.34%	-71031.15%	-23665.31%

Hyperion DeFI Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	2	14	10	0	0
Gross Profit	0	0	0	0	0	1	12	0	0	-3
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-4	-3	-5	-17	-20	-19	-12	-27	-27	-49
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-984.57%	-92.80%	-277.31%	-719859.94%	-86888.57%

Global Institutional Holdings in Hyperion DeFI Inc

Funds	Holdings
Geode Capital Management, LLC	0.19%
Advisor Group Holdings, Inc.	0%
Lasry Marc	1.06%
JPMorgan Chase & Co	0%
PFG Investments, LLC	0%

See all

About Hyperion DeFI Inc

Eyenovia, Inc. is an ophthalmic technology company. The Company is developing and commercializing advanced products leveraging its proprietary Optejet topical ophthalmic medication dispensing platform. The Optejet is especially useful in chronic front-of-the-eye diseases due to its potential for superior compliance versus standard eye drops. The Company’s commercial portfolio includes clobetasol propionate ophthalmic suspension, 0.05%, for post-surgical pain and inflammation, and Mydcombi for mydriasis. Mydcombi is an FDA-approved fixed combination of the two pupil dilation drugs, tropicamide and phenylephrine, delivered with its Optejet technology. The product is indicted to induce mydriasis (pupil dilation) for routine diagnostic procedures and in conditions where short-term pupil dilation is desired. MicroLine is its investigational proprietary microdosed version of pilocarpine, an ophthalmic medication that can dose-dependently induce miosis, or contraction of the pupil.

Organisation	Hyperion DeFI Inc
E-voting on shares	Click here to vote

FAQs

What is Hyperion DeFI Inc share price today?

Hyperion DeFI Inc share price today is $15.8 as on July 3, 2025 at 1:29 am IST at the close of the market. Hyperion DeFI Inc share today touched a day high of $15.81 and a low of $15.81.

What is the 52 week high and 52 week low for Hyperion DeFI Inc share?

Hyperion DeFI Inc share touched a 52 week high of $14.33 on June 30, 2025 and a 52 week low of $1.03 on May 7, 2025. Hyperion DeFI Inc stock price today i.e. July 3, 2025 at 1:29 am IST is closed at $15.8,which is -10.26% down from its 52 week high and 1433.98% up from its 52 week low.

How to invest in Hyperion DeFI Inc Stock (EYEN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Hyperion DeFI Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Hyperion DeFI Inc Shares that will get you 0.0949 shares as per Hyperion DeFI Inc share price of $15.8 per share as on July 3, 2025 at 1:29 am IST.

What is the minimum amount required to buy Hyperion DeFI Inc Stock (EYEN) from India?

Indian investors can start investing in Hyperion DeFI Inc (EYEN) shares with as little as ₹94.61 or $1 (as of May 7, 2026 at 4:07 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹946.10 in Hyperion DeFI Inc stock (as per the Rupee-Dollar exchange rate as on May 7, 2026 at 4:07 pm IST). Based on Hyperion DeFI Inc share’s latest price of $15.8 as on July 3, 2025 at 1:29 am IST, you will get 0.6329 shares of Hyperion DeFI Inc. Learn more about fractional shares .